Guest guest Posted July 18, 2012 Report Share Posted July 18, 2012 WASHINGTON – The Food and Drug Administration on Monday approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes AIDS. The agency approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV through sexual activity, such as those who have HIV-infected partners. Public health advocates say the approval could help slow the spread of HIV, which has held steady at about 50,000 new infections per year for the past 15 years. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.